Video

Dr. Tempero Discusses Hereditary Pancreatic Cancer

Margaret A. Tempero, MD, director, Pancreas Center, University of California, San Francisco, discusses the two main types of hereditary pancreatic cancer.

Margaret A. Tempero, MD, director, Pancreas Center, University of California, San Francisco, discusses the two main types of hereditary pancreatic cancer.

Some types of hereditary pancreatic cancer can be defined by a genetic alteration, such as the BRCA mutation syndromes or hereditary nonpolyposis colorectal cancer syndromes. However, there are also patients that do not have a known genetic determinant but yet pancreatic cancer still seems to run in the family.

If an individual has one affected first-degree relative, their risk goes up, Tempero says. The risk continues to increase as the number of first-degree relatives diagnosed with pancreatic cancer increases. Tempero says there are a number of these families that are being followed. It is likely, Tempero says, that each family has a different genetic reason for getting this cancer. Therefore, there is not a common genetic mutation and each family needs to be investigated separately.

<<<

View more from the 2014 World GI Congress

Related Videos
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.